🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great to be at my first ARCP as dTPD for cardiology in South Yorkshire yesterday. Such world class cardiology talent being nurtured in the steel city & it’s surrounds. Frankie Mark Mills Ryan Crapper Ejaz Rebecca Gosling & others.

Can Pulmonary Artery Denervation reshape the future of group 2 PH management? @YulNunezVill presents promising early data on #PADN using the Gradient Denervation System in HF patients with Group 2 PH: 📍 #PADN led to ⬆️ in pulmonary hemodynamics & ⬇️ #RV afterload in combined

The pulmonary artery denervation clinical study using the gradient denervation system in heart failure patients with pulmonary hypertension group 2 – watch the #HFASnacks where Julio Nunez Villota and Dana Dawson along with host Novi Yanti Sari discuss it. Only at

In the latest issue! Therapeutic potential of allosteric HECT E3 ligase inhibition dlvr.it/TKqmbX

Congratulations to Prof Alexander Rothman who has received the Michael Davies Early Career Award at #BCS2025. We’re so proud to have been part of your research journey as you continue develop more accessible and empowering ways to treat people with Pulmonary Hypertension.

Packed house for the BCS Young Investigators session - fantastic presentations !

And the BCS Young Investigators award winner is Dan Taylor ! Paul Morris Sheffield Uni - Clinical Medicine 🦠 💉 🫀💙🔬🩺 Insigneo Institute

Love this sub stack on our Imatinib trial. The author completely ‘gets’ the big implications of our neat, nimble design. Alex Rothman MRC Biostatistics Unit Sofia S. Villar drugdevelop.substack.com/p/small-trials…

Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 Study American Thoracic Society (ATS) #PAH 🔓Open Access 🔗atsjournals.org/doi/full/10.11…